New drug combo tested for rare liver disease
NCT ID NCT06591455
Summary
This small pilot study tested whether adding fenofibrate to standard treatment helps people newly diagnosed with primary biliary cholangitis, a rare autoimmune liver disease. The study involved 30 participants who were randomly assigned to receive either the combination treatment or standard care alone. Researchers measured liver enzyme levels and symptoms like itching and fatigue to see if the combination was more effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS (PBC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xijing hospital
Xi'an, Shaanxi, 710032, China
Conditions
Explore the condition pages connected to this study.